ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2017
Ocrelizumab and Other CD20
Jeffrey M Gelfand et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
111 papers cite itlatest 60 shown
this paperpooled ittrialcites it